The aims of this study were to elucidate the relationships between IGF1 genotype, early-onset breast cancer, breast volume, circulating IGF-1 levels, pregnancy and OC use in a prospective cohort of healthy premenopausal women from high-risk breast cancer families. Here, IGF1 is linked to breast cancer.